InsidersTradesSigma
Track the Diamyd Medical Aktiebolag share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Market capitalisation: €158.4m. The latest transaction was filed on 27 July 2026 (Purchase). Among the most active insiders: Anders Essen-Möller. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Diamyd Medical Aktiebolag is a Swedish biopharmaceutical company focused on developing treatments for type 1 diabetes. It is listed on the Stockholm Stock Exchange.